Disrupted transforming growth factor-β signaling and deregulated growth in human biliary tract cancer cells

International Journal of Cancer

Volumn 86, Issue 6, 2000, Pages 782-789

  Yazumi, Shujiro ^a   Ko, Kohaku ^a   Watanabe, Norihiko ^a   Shinohara, Hisashi ^a   Yoshikawa, Kiyotsugu ^a   Chiba, Tsutomu ^a   Takahashi, Rei ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INVASION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BILIARY TRACT NEOPLASMS; DNA-BINDING PROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0034660412     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000615)86:6<782::AID-IJC5>3.0.CO;2-O     Document Type: Article

References (26)

1. DE CAESTECKER, M.P., HEMMATI, P., LARISCH-BLOCH, S., AJMERA, R., ROBERTS, A.B. and LECHLEIDER, R.J., Characterization of functional domains within Smad4/DPC4. J. Biol. Chem., 272, 13690-13696 (1997).
2. DE WINTER, J.P., ROELEN, B.A., TEN DIJKE, P., VAN DER BURG, B. and VAN DEN EIJNDEN-VAN RAAIJ, A.J., DPC4 (SMAD4) mediates transforming growth factor-betal (TGF-betal) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene, 14, 1891-1899 (1997).
3. DENNLER, S., ITOH, S., VIVIEN, D., TEN DIJKE, P., HUET, S. and GAUTHIER, J.M., Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J., 17, 3091-3100 (1998).
4. EPPERT, K. and 12 OTHERS, MADR2 maps to 18q21 and encodes a TGF-ßeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543-552 (1996).
5. HAHN, S.A., BARTSCH, D., SCHROERS, A., GALEHDARI, H., BECKER, M., RAMASWAMY, A., SCHWARTE-WALDHOFF, I., MASCHEK, H. and SCHMIEGEL, W., Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res., 58, 1124-1126 (1998).
6. HAHN, S.A., SCHUTTE, M., HOQUE, A.T., MOSKALUK, CA., DA COSTA, L.T., ROZENBLUM, E., WEINSTEIN, C.L., FISCHER, A., YEO, C.J., HRUBAN, R.H. and KERN, S.E., DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-353 (1996).
7. HATA, A., Lo, R.S., WOTTON, D., LANGA, G. and MASSAGUE, J., Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature (Land.), 388, 82-87 (1997).
8. HELDIN, C.H., MIYAZONO, K. and TEN DUKE, P., TGF-ßeta signalling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390, 465-471 (1997).
9. KAGEYAMA, H., SEKI, N., YAMADA, S., SAKIYAMA, S. and NAKAGAWARA, A., DPC4 splice variants in neuroblastoma. Cancer Lett., 122, 187-193 (1998).
10. KUROKAWA, M., MITANI, K., IRIE. K., MATSUYAMA, T., TAKAHASHI, T., CHIBA, S., YAZAKI, Y., MATSUMOTO, K. and HIRAI, H., The oncoprotein Evi-1 represses TGF-ß signalling by inhibiting Smad3. Nature (Lond.), 394, 92-96 (1998).
11. LEVI, S., URBANO-ISPIZUA, A., GILL, R., THOMAS, D.M., GILBERTSON, J., FOSTER, C. and MARSHALL, C.J., Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51, 3497-3502 (1991).
12. Lo, R.S., CHEN, Y.G., SHI, Y., PAVLETICH, N.P. and MASSAGUÉ. J., The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-ßeta receptors. Embo J., 17, 996-1005 (1998).
13. MAHARA, K., KATO, J., TERUI, T., TAKIMOTO, R., HORIMOTO, M., MURAKAMI, T., MOGI, Y., WATANABE, N., KOHGO, Y. and NIITSU, Y., Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. Br. J. Cancer, 69, 777-783 (1994).
14. PARSONS, R., MYEROFF, L.L., LIU, B., WILLSON, J.K., MARKOWITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550 (1995).
15. PIEK, E., WESTERMARK, U., KASTEMAR, M., HELDIN, C.H., VAN ZOELEN, E.J., NISTER, M. and TEN DIJKE, P.T., Expression of transforming-growth-factor (TGF)-ß receptors and SMAD proteins in glioblastoma cell lines with distinct response to TGF-ß1. Int. J. Cancer, 80, 756-763 (1999).
16. PITT, H.A., DOOLEY, W.C., YEO, C.J., CAMERON, J.L., Malignancies of the biliary tract. In: S.A. Wells (ed.), Current problems in surgery, Vol. 32, pp. 6-90. Mosby-Yearbook, St. Louis (1995).
17. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T., Analysis of RNA. In: Molecular cloning, Vol. 1, 2nd Ed., pp. 7.37-7.52. Cold Spring Harbor Laboratory Press, New York (1989).
18. SPORN, M.B., ROBERTS, A.B., WAKEFIELD, L.M. and ASSOIAN, R.K., Transforming growth factor-beta: Biological function and chemical structure. Science, 233, 532-534 (1986).
19. TAKAKU, K., OSHIMA, M., MIYOSHI, H., MATSUI, M., SELDIN, M.F. and TAKETO, M.M., Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell, 92, 645-656 (1998).
20. TAKENOSHITA, S., TANI, M., MOGI, A., NAGASHIMA, M., NAGAMACHI, Y., BENNETT, W.P., HAGIWARA, K., HARRIS, C.C. and YOKOTA, J., Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis, 19, 803-807 (1998).
21. TEH, M., WEE, A. and RAJU, G.C., An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer, 74, 1542-1545 (1994).
22. TOGO, G., TODA, N., KANAI, F., KATO, N., SHIRATORI, Y., KISHI, K., IMAZEKI, F., MAKUUCHI, M. and OMATA, M., A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res., 56, 5620-5623 (1996).
23. VINCENT, F., NAGASHIMA, M., TAKENOSHITA, S., KHAN, M.A., GEMMA, A., HAGIWARA, K. and BENNETT, W.P., Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene. 15, 117-122 (1997).
24. WANG, J., HAN, W., ZBOROWSKA, E., LIANG, J., WANG, X., WILLSON, J.K. V., SUN, L. and BRATTAIN, M.G., Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem., 271, 17366-17371 (1996).
25. YOSHIDA, S., TODOROKI, T., ICHIKAWA, Y., HANAI, S., SUZUKI, H., HORI, M., FUKAO, K., MIWA, M. and UCHIDA, K., Mutations of p16Ink4/CDKN2 and p15Ink4BMTS2 genes in biliary tract cancers. Cancer Res., 55, 2756-2760 (1995).
26. ZHU, Y., RICHARDSON, J.A., PARADA, L.F. and GRAFF, J.M., Smad3 mutant mice develop metastatic colorectal cancer. Cell, 94, 703-714 (1998).